Profusa Inc (PFSA)

$0.54 -0.01 (-2.50%)
Market Cap 2.45M
Revenue (ttm) 0.00
Net Income (ttm) -35.82M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.51
Volume 939,000
Avg Vol 6,248,082
Day's Range N/A - N/A
Shares Out 4.41M
Stochastic %K 33%
Beta 0.28
Analysts Strong Buy
Price Target N/A

Company Profile

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Industry: Medical Devices
Sector: Healthcare
Phone: 925 997 6925
Website: profusa.com
Address:
626 Bancroft Way, Suite A, Berkeley, United States
M421
M421 Apr. 29 at 9:10 AM
$CYCU $PFSA $KITT $ATER
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 8:06 PM
$PFSA feels like it’s setting up for another push
0 · Reply
Cremonix
Cremonix Apr. 28 at 8:04 PM
$BTBD This is big!! The company they are merging with has announced they are partnering with an engineering firm to develop next-generation drone technology for the US military. This really broadens the capabilities of the new company and galvanizes them firmly into the military drone theme and serves as a kind of brazen shot across the bow of the established companies within the sector. $PFSA $SEGG $RPGL $ATER
0 · Reply
Hydrojim
Hydrojim Apr. 28 at 7:52 PM
$PFSA $FFAI
0 · Reply
Joijoi
Joijoi Apr. 28 at 7:10 PM
$PFSA from Top gapper to red and from red to green. Very interesting. Will keep watching
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 6:19 PM
$PFSA RSI: 12.37, MACD: -0.1830 Vol: 0.33, MA20: 0.78, MA50: 0.89 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
STLHD
STLHD Apr. 28 at 5:33 PM
$PFSA @Nuclear_Elvis up 12% today. I'd like to hear from other investors why they're holding Profusa.
2 · Reply
mrtallman
mrtallman Apr. 28 at 5:28 PM
$PFSA 🚀
0 · Reply
Hydrojim
Hydrojim Apr. 28 at 5:23 PM
$PFSA
0 · Reply
mrtallman
mrtallman Apr. 28 at 5:14 PM
$PFSA
0 · Reply
Latest News on PFSA
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Apr 6, 2026, 6:00 AM EDT - 23 days ago

Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Feb 27, 2026, 9:15 AM EST - 2 months ago

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Feb 19, 2026, 8:30 AM EST - 2 months ago

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Feb 13, 2026, 8:30 AM EST - 2 months ago

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Feb 5, 2026, 8:00 AM EST - 2 months ago

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Jan 29, 2026, 8:00 AM EST - 3 months ago

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Profusa Stock Spikes As Lumee System Targets Research Market

Jan 16, 2026, 12:51 PM EST - 3 months ago

Profusa Stock Spikes As Lumee System Targets Research Market

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Jan 16, 2026, 7:30 AM EST - 3 months ago

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Jan 8, 2026, 7:30 AM EST - 3 months ago

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Dec 31, 2025, 7:30 AM EST - 4 months ago

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Dec 30, 2025, 4:22 PM EST - 4 months ago

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Dec 30, 2025, 7:30 AM EST - 4 months ago

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Dec 15, 2025, 7:30 AM EST - 4 months ago

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Dec 11, 2025, 8:30 AM EST - 4 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Nov 24, 2025, 8:15 AM EST - 5 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Profusa Announces Third Quarter Business and Financial Highlights

Nov 19, 2025, 5:44 PM EST - 5 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Oct 30, 2025, 7:30 AM EDT - 6 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Oct 28, 2025, 8:30 AM EDT - 6 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Oct 22, 2025, 8:30 AM EDT - 6 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Profusa Invests Additional $1 Million in Digital Treasury Assets

Oct 7, 2025, 8:15 AM EDT - 7 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Oct 1, 2025, 8:30 AM EDT - 7 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Sep 11, 2025, 8:30 AM EDT - 8 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Sep 4, 2025, 8:30 AM EDT - 8 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Aug 27, 2025, 8:45 AM EDT - 8 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Aug 19, 2025, 8:15 AM EDT - 9 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Aug 6, 2025, 8:15 AM EDT - 9 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Jul 31, 2025, 8:15 AM EDT - 9 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Jul 21, 2025, 8:00 AM EDT - 10 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Jul 11, 2025, 4:00 PM EDT - 10 months ago

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

M421
M421 Apr. 29 at 9:10 AM
$CYCU $PFSA $KITT $ATER
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 8:06 PM
$PFSA feels like it’s setting up for another push
0 · Reply
Cremonix
Cremonix Apr. 28 at 8:04 PM
$BTBD This is big!! The company they are merging with has announced they are partnering with an engineering firm to develop next-generation drone technology for the US military. This really broadens the capabilities of the new company and galvanizes them firmly into the military drone theme and serves as a kind of brazen shot across the bow of the established companies within the sector. $PFSA $SEGG $RPGL $ATER
0 · Reply
Hydrojim
Hydrojim Apr. 28 at 7:52 PM
$PFSA $FFAI
0 · Reply
Joijoi
Joijoi Apr. 28 at 7:10 PM
$PFSA from Top gapper to red and from red to green. Very interesting. Will keep watching
1 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 28 at 6:19 PM
$PFSA RSI: 12.37, MACD: -0.1830 Vol: 0.33, MA20: 0.78, MA50: 0.89 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
STLHD
STLHD Apr. 28 at 5:33 PM
$PFSA @Nuclear_Elvis up 12% today. I'd like to hear from other investors why they're holding Profusa.
2 · Reply
mrtallman
mrtallman Apr. 28 at 5:28 PM
$PFSA 🚀
0 · Reply
Hydrojim
Hydrojim Apr. 28 at 5:23 PM
$PFSA
0 · Reply
mrtallman
mrtallman Apr. 28 at 5:14 PM
$PFSA
0 · Reply
mrtallman
mrtallman Apr. 28 at 5:08 PM
$PFSA this will explode. Mark my words
1 · Reply
mrtallman
mrtallman Apr. 28 at 5:07 PM
$PFSA $5
1 · Reply
DayTrade_4Life
DayTrade_4Life Apr. 28 at 3:02 PM
🔥Top Alerts so far Today 28 April: 👀See Profile for more information. BIYA: 1.25 to 2.19 (75%) ATER: 1 to 1.51 (51%) SNBR: 2.85 to 4.24 (48%) SEGG: 1.05 to 1.36 (29%) MLEC: 9.45 to 11.84 (25%) $SBLX: 2.90 to 3.59 (23%) $KIDZ: 1.20 to 1.44 (20%) $POLA: 2 to 2.39 (19%) $BBBY: 6.60 to 7.70 (16%) $PFSA: .63 to .72 (14%)
0 · Reply
StMichaelTwits
StMichaelTwits Apr. 28 at 2:31 PM
$PFSA This is not ready until mid to late fall for entry. On watch..
1 · Reply
Ozcorp
Ozcorp Apr. 28 at 1:20 PM
$CTNT $FTEK $PFSA $SNBR
0 · Reply
alby777
alby777 Apr. 28 at 1:08 PM
$WLGS shares primarily trade on the OTC under the ticker WLGSF currently @ $0.0084! Who wants to be a Millionaire? Great Risk/Reward!? $TROO $ATCH $PFSA $AIXI https://www.globenewswire.com/news-release/2025/03/31/3052260/0/en/WANG-AND-LEE-GROUP-INC-ANNOUNCES-STRATEGIC-INVESTMENT-IN-TROOPS-INC-TO-DRIVE-INNOVATION-IN-SMART-BUILDING-SOLUTIONS-AND-EXPAND-ESG-TOKEN-REWARD-ECOSYSTEM.html
1 · Reply
Dickman777
Dickman777 Apr. 28 at 1:07 PM
$CTNT $FTEK $PFSA $SNBR $CYCU cycu going to print really soon!!
0 · Reply
Khaiman
Khaiman Apr. 28 at 1:07 PM
$PFSA Y does everyone here like $IMUX and $DRCT Y?? They related in some whay like $IMUX is it the tiny float? YYYYYYYYY?
0 · Reply
Nuclear_Elvis
Nuclear_Elvis Apr. 28 at 12:53 PM
$PFSA Profusa just graduated to Garbage Paper and will dilute the stock through Ascent Partners. Key Quote, "We will not receive any of the proceeds from the sale of Common Stock by the Selling Shareholders. However, we may receive up to $100,000,000 in aggregate gross proceeds from sales of the Purchase Shares to Ascent that we may, in our discretion, elect to make, from time to time after the date of this prospectus." Link to SEC filed S-1 today: https://www.sec.gov/ix?doc=/Archives/edgar/data/0001859807/000121390026048288/ea0287086-s1_profusa.htm
1 · Reply
Nuclear_Elvis
Nuclear_Elvis Apr. 28 at 12:45 PM
$PFSA Nearly 20 million shares traded in the Pre-Market. Some of that could be the company dumping shares as part of the $10 million they are desperately trying to raise, per the 8-K filed on April 26th.
0 · Reply
jeni1988
jeni1988 Apr. 28 at 12:23 PM
$PFSA 😂😂😂😂😂🤡🤡🤡🤡🤡🤡
0 · Reply
Kesiya
Kesiya Apr. 28 at 12:20 PM
$PFSA Exit
0 · Reply